Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fetuin-B is a secreted glycoprotein, part of the fetuin family within the cystatin superfamily, and acts as a highly selective and potent inhibitor of astacin-family metalloendopeptidases, particularly ovastacin. By preventing premature zona pellucida hardening in mammalian oocytes, it is critical for female fertility. Beyond reproductive roles, fetuin-B may participate in diverse biological processes including bone metabolism, insulin signaling regulation, and modulation of inflammatory responses. It is distinct from, but structurally related to, fetuin-A. Human FETUB is encoded on chromosome 3, with protein encoded in multiple vertebrates. No approved drugs target fetuin-B directly, and its main significance lies in endogenous regulation rather than as a traditional therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fetuin-B (FETUB).